On October 20, 2009
Pfizer Q3: Healthy Profit Masks Revenue Decline
This merger with Wyeth can’t come soon enough for Pfizer. The company’s revenues were down 3 percent to $11.6 billion in Q3 2009, although net income was $2.8 billion up 26 percent. That healthy profit growth masks the reality of Pfizer’s business: Of all its drugs, only four saw growth.
0 Comments